Chicago Atlantic Real Estate Finance Inc Dossier - Source-backed chat

Chicago Atlantic Real Estate Finance Inc

REFINASDAQ

SectorReal Estate

IndustryMortgage REITs

Beta (adjusted)0.50

Intrinsic Value $10.83median of 1 methodbased on filings through 30 Jun 2026

Market Price $9.93Price as of 1 Oct 2026

Near fair valueIntrinsic value is 9% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $254.4M

Enterprise Value $290.5M

Shares Outstanding 25.6M diluted

Next Earnings Date31 Dec 2026

Last ex-dividend30 Jun 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Chicago Atlantic Real Estate Finance, Inc. (REFI) has entered into a definitive, transformative merger agreement with its affiliate Chicago Atlantic BDC, Inc. (LIEN) as of June 18, 2026. Under the agreement, REFI will elect to be regulated as a Business Development Company (BDC) and merge into LIEN in an all-stock, NAV-for-NAV transaction expected to close in Q4 2026. While REFI continues to generate stable distributable earnings ($0.47 per share in Q1 2026) that fully cover its $0.47 quarterly dividend, its GAAP earnings have been pressured by higher credit loss provisions ($3.8 million CECL provision in Q1 2026), and book value has declined to $14.39. The upcoming merger will double the combined platform's portfolio size to $771 million and NAV to $613 million, creating a scaled BDC. However, near-term upside is capped by the fixed NAV-for-NAV exchange structure and credit quality headwinds in the cannabis sector, justifying a Hold rating until the merger is finalized.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026

Low · most bearish analyst$13.50

Mean target$16.38

High · most bullish analyst$20.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The merger faces regulatory delays or fails to obtain stockholder approval, leaving REFI to operate independently as a mortgage REIT in a highly constrained cannabis real estate market. Credit quality deteriorates further, requiring additional heavy CECL provisions, which forces a reduction in the quarterly dividend payout below the historical $0.47 per share level.

Base CaseCentral scenario

The merger with LIEN is approved by stockholders of both companies and successfully closes in Q4 2026. REFI stockholders receive LIEN common stock based on the final adjusted NAV-for-NAV ratio (expected to result in former REFI stockholders owning approximately 50.5% of the combined entity). The combined BDC achieves greater scale, diversifies its portfolio across cannabis and lower middle market segments, and implements a post-closing stock repurchase program of up to $25 million, stabilizing the share price near its combined NAV.

Bull CaseUpside scenario

Bulls argue that REFI's high-yield lending in cannabis real estate can support strong margins over time, and the current 65.9% trailing margin lines up with that. Supporters point to weighted average loan yields around the high teens and the 5-year average earnings growth of 10.1% per year as evidence that the model can produce healthy profitability.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Transformative merger with LIEN creates a scaled, diversified BDC platform with a pro-forma portfolio of $771 million.
Strong dividend coverage with Q1 2026 Distributable Earnings of $0.47 per share fully covering the $0.47 quarterly dividend.
Robust interest rate floor protection, with 96% of the loan portfolio protected from further prime rate declines.
Significant reduction in non-accrual loans from 11.1% at year-end 2025 to 4.8% as of March 31, 2026.

Key Investment Risks

Transaction risk associated with the pending all-stock merger, including potential NAV adjustments prior to closing.
Elevated credit risk in the cannabis sector, as evidenced by a $3.8 million CECL provision in Q1 2026.
Concentration risk, as the combined entity will remain heavily exposed to the evolving regulatory and competitive landscape of the cannabis industry.

Thesis Invalidation Triggers

Failure of stockholders of either REFI or LIEN to approve the merger agreement.
A material downward adjustment in REFI's NAV per share relative to LIEN's NAV per share prior to closing.
Severe credit defaults in the loan portfolio that impair distributable earnings and threaten the dividend coverage.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.